Effect of Teriflunomide on Cells From Patients With Human T-cell Lymphotropic Virus Type 1-Associated Neurologic Disease

Conclusions
These results suggest that teriflunomide inhibits abnormal T-cell proliferation associated with HTLV-1 infection and may have potential as a therapeutic option in patients with HAM/TSP.

Source: Neurology Neuroimmunology and Neuroinflammation - April 9, 2021 Category: Neurology Authors: Enose-Akahata, Y., Ngouth, N., Ohayon, J., Mandel, M., Chavin, J., Turner, T. J., Jacobson, S. Tags: All Immunology, Viral infections Article Source Type: research